INSAR 2020

COSGeneral news

We are delighted to confirm the following poster was accepted at the INSAR 2020 Virtual event held last week: Understanding Meaningful Changes in Autism Spectrum Disorder Clinical Trial Outcomes Using an Exit Interview Methodology.  Please visit the INSAR 2020 Virtual Meeting hereDownload poster here

Digestive Disease Week 2020

COSGeneral news

Although Digestive Disease Week 2020 was unable to take place, we are very pleased to share our accepted work – Qualitative Patient Interviews to Assess Content Validity of the Modified Dysphagia Symptom Questionnaire. Author(s):  Siddhesh Kamat1, Christopher Hartford4, Isabelle Guillemin5, Jingdong Chao1, Laurent Eckert5, Tara Symonds3, Kathryn A. Peterson2 Please follow this link to search for the poster on the …

7 years of Clinical Outcomes Solutions

COSGeneral news

This month, Clinical Outcome Solutions celebrates seven years at the forefront of continuous, dedicated support across all facets of clinical outcomes research which inform patient care value decisions. The early partnership between Stacie Hudgens and Tara Symonds (2014) has now grown to a global team of three strategic leads, nine research directors and 55 team members, with clients and offices …

Jennifer Beaumont joins COS as Senior Director, Quantitative Science, Biostatistics

COSGeneral news

Clinical Outcomes Solutions is pleased to announce that Jennifer Beaumont has joined the growing team as a Senior Director of Quantitative Sciences – Biostatistics. Jennifer has spent much of her career as a statistical analyst and has worked at the Center for Outcomes Research and Education and at Northwestern University where she was involved in development, validation, and application of …

FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic

COSLinda Howard

The recent FDA guidance on conducting clinical trial during the COVID-19 pandemic mirrors our response policy to minimize study participant contact and engage in phone or video calls wherever possible. Great to see COS is ahead of the curve. Read full FDA guidance as PDF here

The COS team will be attending ISPOR Europe, 2019


The COS leadership team will be attending ISPOR Europe in Copenhagen in November as follows: Hudgens S, Pelletier C, Newton L, Howerter A, Gaines J, Keith S, Ung B, Udeze C, Evans C. Disease burden in patients with mild psoriasis: group concept mapping (PSS23). Presented at the International Society for Pharmacoeconomics and Outcomes Research Europe 2019; Wednesday 6 November, 09:30-14:00 …

COS will be attending ISOQOL


Poster Presentations Monday 21 October Abstract Title: Defining estimands for responder analysis of patient-reported outcomes with missing data Presentation type: Poster (1081) Presentation time: 10:05 Authors: Floden L, Hudgens S, Bell ML. Abstract Title: Group vs Individual Patient Methods to Estimate Meaningful Change Thresholds: A Simulation Study Presentation type: Poster (1069) Presentation time: 10:05 Authors: Doll H, Griffiths P, Gugiu …

Tara Symonds CSO and Stacie Hudgens CEO present on establishing the reliability of the 5 Domain NPCSS ClinRO

COSStacie Hudgens

COS’s Tara Symonds CSO and Stacie Hudgens CEO assisted with establishing the reliability of the 5 Domain NPCSS ClinRO: ‘A Study to assess the Inter and Intra-rater Reliability of the 5 Domain NPCCSS’ NPCCSS Marc Patterson, Christine I Dali, Tara Symonds, Christina Guldberg, Stacie Hudgens, Eugen Mengel. The poster is being presented at ‘Society for the Study of Inborn Errors …

The COS team will be attending ISPOR US, 2019


The COS leadership team will be attending ISPOR US in New Orleans in May as follows: Barsdorf A, Symonds T, Bush N. Introduction to Patient Reported Outcomes (short course). Course date: 18 May 2019; 08:00–12:00 Keith S, Humphrey L, Bozzi S, Reaney M. Using Group Concept Mapping Methodology to Explore COPD Patient Experience and Aid Selection of Patient-reported Outcome Measures …

COS announces oncology-focused research group


In 2018, COS celebrated its 5th anniversary, this year, we are thrilled to announce the launch of Oncology Outcomes: Strategic Advisory Partnership. This oncology-focused research partnership led by Stacie Hudgens is launched in collaboration with global thought-leader, Alicyn Campbell. This innovative partnership will expand the resources and expertise available to our clients, further strengthening COS’s position at the forefront of …